Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Greenberg Sells 276 Nayax Shares at $48.55 for Tax Withholding

Aaron Samuel Greenberg, Chief Security Officer of Nayax Ltd., filed a statement of changes in beneficial ownership on November 3, 2026, reporting a sale of 276 ordinary shares on November 2, 2026.

Shwetambri Chauhan | 03 November 2026

Citigroup SPXI4EV6 5-Year Buffered Autocallable Note Terms

Citigroup Global Markets Holdings Inc., guaranteed by Citigroup Inc., filed a free writing prospectus on November 3, 2026, setting out preliminary terms for 5-year buffered autocallable securities linked to the S&P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER (ticker: …

Aakashdeep | 03 November 2026

Crocs Director Frasch Sells 15,000 Shares at $153.51

Director Ronald Frasch filed a Form 4 with the SEC on November 3, 2026, disclosing the sale of 15,000 shares of Crocs, Inc. common stock on October 30, 2026.

Shwetambri Chauhan | 03 November 2026

Citigroup Autocallable Notes on SPXI4EV6 Priced November 2026

Citigroup Global Markets Holdings Inc. filed a free writing prospectus on November 3, 2026, disclosing preliminary terms for 5-Year Autocallable Contingent Coupon Securities linked to the S&P 500 Futures 40% Intraday Edge Volatility TCA 6% Decrement Index (USD) ER, with a pricing date of …

Anjali Anand | 03 November 2026

THOR Industries 2026 Annual Meeting Proxy Statement

THOR Industries, Inc. filed a definitive proxy statement on November 3, 2026, notifying shareholders of its 2026 Annual Meeting to be held virtually on December 16, 2026, and disclosing key fiscal year 2026 financial and operational results.

Anjali Anand | 03 November 2026

Thor Industries Reports $9.61B in Sales for Fiscal 2026

Thor Industries, Inc. filed its Annual Report on Form 10-K for the fiscal year ended July 31, 2026, disclosing consolidated net sales of $9.61 billion and net income attributable to the company of $177.5 million.

Anjali Anand | 03 November 2026

Kairos Pharma Extends Helena ELOC to December 31, 2028

Kairos Pharma, Ltd. filed a Form 8-K with the SEC on November 3, 2026, disclosing three amendments to its equity line of credit purchase agreement with Helena Global Investment Opportunities I Ltd. and announcing a clinical data presentation by its President and Chief Scientific …

Vinay Lochav | 03 November 2026

Unilever 2026 Investor Event: HPC Pureplay Strategy Outlined

Unilever PLC filed a Form 6-K with the SEC on November 3, 2026, disclosing plans presented at its 2026 Investor Event covering a new operating model, leadership changes, financial targets, and productivity goals as the company transitions to a focused home and personal care …

Manish Choudhary | 03 November 2026

Philip Davies Sells 2,573 Vicor Shares on Nov. 2, 2026

Philip D. Davies, Corporate VP of Global Sales and Marketing and a Director at Vicor Corp (NASDAQ:VICR), filed a Form 4 on November 3, 2026, disclosing the exercise of stock options and the sale of common stock on November 2, 2026, pursuant to a …

Nitish Kishor | 03 November 2026

Generac Officer Raabe Plans Sale of 598 Shares via Rule 144

Kyle Andrew Raabe, an officer of Generac Holdings Inc., filed a Form 144 notice of proposed sale of 598 shares of common stock on November 3, 2026, through Fidelity Brokerage Services LLC on the NYSE.

Aakashdeep | 03 November 2026
Support

Hi! How can we help you today?

Loading…